Clinical Trial Update: A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating bone metabolism and blood sugar effects of evogliptin and dapagliflozin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Diseases Metabolic
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Evogliptin (evogliptin)

Snippet

Sponsor: Kyung Hee University Hospital at Gangdong | Conditions: Bone Diseases, Metabolic, Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN